Cargando…
Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif
Mutations in LRRK2 (leucine-rich repeat kinase 2) have been identified as major genetic determinants of Parkinson's disease (PD). The most prevalent mutation, G2019S, increases LRRK2's kinase activity, therefore understanding the sites and substrates that LRRK2 phosphorylates is critical t...
Autores principales: | Pungaliya, Pooja P., Bai, Yuchen, Lipinski, Kerri, Anand, Vasanti S., Sen, Saurabh, Brown, Eugene L., Bates, Brian, Reinhart, Peter H., West, Andrew B., Hirst, Warren D., Braithwaite, Steven P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965117/ https://www.ncbi.nlm.nih.gov/pubmed/21060682 http://dx.doi.org/10.1371/journal.pone.0013672 |
Ejemplares similares
-
Inhibitors of Leucine Rich Repeat Kinase 2 (LRRK2) Protect Against LRRK2-Models of Parkinson’s Disease
por: Lee, Byoung Dae, et al.
Publicado: (2010) -
Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies
por: Davies, Paul, et al.
Publicado: (2013) -
Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity
por: Fernández, Belén, et al.
Publicado: (2022) -
Perspective on the current state of the LRRK2 field
por: Taymans, Jean-Marc, et al.
Publicado: (2023) -
Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2):
Parkinson’s disease and beyond
por: Bae, Jae Ryul, et al.
Publicado: (2015)